Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes
Diabetes Care · 2024
DOI: 10.2337/dc23-1679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Diabetes Care, 2024. Verfasst von Yu Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Intramural CDC HHS.
Themen: Diabetes mellitus
Abstract (Originalsprache)
OBJECTIVE To compare total and out-of-pocket (OOP) medical expenditures between pre–COVID-19 (March 2019 to February 2020) and COVID-19 (March 2020 to February 2022) periods among Medicare beneficiaries with diabetes. RESEARCH DESIGN AND METHODS Data were from 100% Medicare fee-for-service claims. Diabetes was identified using ICD-10 codes. We calculated quarterly total and OOP medical expenditures at the population and per capita level in total and by service type. Per capita expenditures were calculated by dividing the population expenditure by the number of beneficiaries with diabetes in the same quarter. Changes in expenditures were calculated as the differences in the same quarters between the prepandemic and pandemic years. RESULTS Population total expenditure fell to $33.6 billion in the 1st quarter of the pandemic from $41.7 billion in the same prepandemic quarter; it then bounced back to $36.8 billion by the 4th quarter of the 2nd pandemic year. The per capita total expenditure fell to $5,356 in the 1st quarter of the pandemic from $6,500 in the same prepandemic quarter. It then increased to $6,096 by the 4th quarter of the 2nd pandemic year, surpassing the same quarter in the prepandemic year ($5,982). Both population and per capita OOP expenditures during the pandemic period were lower than the prepandemic period. Changes in per capita expenditure between the pre–COVID-19 and COVID-19 periods by service type varied. CONCLUSIONS COVID-19 had a significant impact on both total and per capita medical expenditures among Medicare beneficiaries with diabetes. The COVID-19 pandemic was associated with lower OOP expenditures.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA.
ORCID-Profile: Yu Wang, Ping Zhang
Förderung
- Intramural CDC HHS
Zitieren
APA
Wang, Y., Zhang, P., Zhou, X., Rolka, D., & Imperatore, G. (2024). Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes. Diabetes Care. https://doi.org/10.2337/dc23-1679
Vancouver
Wang Y, Zhang P, Zhou X, Rolka D, Imperatore G. Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes. Diabetes Care. 2024. doi:10.2337/dc23-1679
BibTeX
@article{Wang2024,
author = {Wang, Yu and Zhang, Ping and Zhou, Xilin and Rolka, Deborah and Imperatore, Giuseppina},
title = {Impact of the COVID-19 Pandemic on Medical Expenditures Among Medicare Fee-for-Service Beneficiaries Aged ≥67 Years With Diabetes},
journal = {Diabetes Care},
year = {2024},
doi = {10.2337/dc23-1679}
}
EUVIMED